Literature DB >> 19502066

Molecular recognition in the P2Y(14) receptor: Probing the structurally permissive terminal sugar moiety of uridine-5'-diphosphoglucose.

Hyojin Ko1, Arijit Das, Rhonda L Carter, Ingrid P Fricks, Yixing Zhou, Andrei A Ivanov, Artem Melman, Bhalchandra V Joshi, Pavol Kovác, Jan Hajduch, Kenneth L Kirk, T Kendall Harden, Kenneth A Jacobson.   

Abstract

The P2Y(14) receptor, a nucleotide signaling protein, is activated by uridine-5'-diphosphoglucose 1 and other uracil nucleotides. We have determined that the glucose moiety of 1 is the most structurally permissive region for designing analogues of this P2Y(14) agonist. For example, the carboxylate group of uridine-5'-diphosphoglucuronic acid proved to be suitable for flexible substitution by chain extension through an amide linkage. Functionalized congeners containing terminal 2-acylaminoethylamides prepared by this strategy retained P2Y(14) activity, and molecular modeling predicted close proximity of this chain to the second extracellular loop of the receptor. In addition, replacement of glucose with other sugars did not diminish P2Y(14) potency. For example, the [5'']ribose derivative had an EC(50) of 0.24muM. Selective monofluorination of the glucose moiety indicated a role for the 2''- and 6''-hydroxyl groups of 1 in receptor recognition. The beta-glucoside was twofold less potent than the native alpha-isomer, but methylene replacement of the 1''-oxygen abolished activity. Replacement of the ribose ring system with cyclopentyl or rigid bicyclo[3.1.0]hexane groups abolished activity. Uridine-5'-diphosphoglucose also activates the P2Y(2) receptor, but the 2-thio analogue and several of the potent modified-glucose analogues were P2Y(14)-selective.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19502066      PMCID: PMC2760346          DOI: 10.1016/j.bmc.2009.05.024

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  37 in total

Review 1.  P2Y receptors: biological advances and therapeutic opportunities.

Authors:  S R Shaver
Journal:  Curr Opin Drug Discov Devel       Date:  2001-09

2.  The retinal conformation and its environment in rhodopsin in light of a new 2.2 A crystal structure.

Authors:  Tetsuji Okada; Minoru Sugihara; Ana-Nicoleta Bondar; Marcus Elstner; Peter Entel; Volker Buss
Journal:  J Mol Biol       Date:  2004-09-10       Impact factor: 5.469

Review 3.  Regulation of platelet functions by P2 receptors.

Authors:  Christian Gachet
Journal:  Annu Rev Pharmacol Toxicol       Date:  2006       Impact factor: 13.820

4.  The inflammatory effects of UDP-glucose in N9 microglia are not mediated by P2Y14 receptor activation.

Authors:  Vielska M Brautigam; George R Dubyak; Jessica M Crain; Jyoti J Watters
Journal:  Purinergic Signal       Date:  2008-02-08       Impact factor: 3.765

5.  Phosphoinositide hydrolysis by guanosine 5'-[gamma-thio]triphosphate-activated phospholipase C of turkey erythrocyte membranes.

Authors:  T K Harden; P T Hawkins; L Stephens; J L Boyer; C P Downes
Journal:  Biochem J       Date:  1988-06-01       Impact factor: 3.857

6.  Synthesis of enantiomerically pure (S)-methanocarbaribo uracil nucleoside derivatives for use as antiviral agents and P2Y receptor ligands.

Authors:  Artem Melman; Minghong Zhong; Victor E Marquez; Kenneth A Jacobson
Journal:  J Org Chem       Date:  2008-09-24       Impact factor: 4.354

7.  A convenient synthesis of the C-1-phosphonate analogue of UDP-GlcNAc and its evaluation as an inhibitor of O-linked GlcNAc transferase (OGT).

Authors:  Jan Hajduch; Ghilsoo Nam; Eun Ju Kim; Roland Fröhlich; John A Hanover; Kenneth L Kirk
Journal:  Carbohydr Res       Date:  2007-11-01       Impact factor: 2.104

8.  The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist.

Authors:  Veli-Pekka Jaakola; Mark T Griffith; Michael A Hanson; Vadim Cherezov; Ellen Y T Chien; J Robert Lane; Adriaan P Ijzerman; Raymond C Stevens
Journal:  Science       Date:  2008-10-02       Impact factor: 47.728

9.  Synthesis and P2Y receptor activity of nucleoside 5'-phosphonate derivatives.

Authors:  Liesbet Cosyn; Serge Van Calenbergh; Bhalchandra V Joshi; Hyojin Ko; Rhonda L Carter; T Kendall Harden; Kenneth A Jacobson
Journal:  Bioorg Med Chem Lett       Date:  2009-04-14       Impact factor: 2.823

10.  Synthesis of ethyl (1S,2R,3S,4S,5S)-2,3-O-(isopropylidene)-4-hydroxy-bicyclo[3.1.0]hexane-carboxylate from L-ribose: a versatile chiral synthon for preparation of adenosine and P2 receptor ligands.

Authors:  Bhalchandra V Joshi; Artem Melman; Richard L Mackman; Kenneth A Jacobson
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2008-03       Impact factor: 1.381

View more
  17 in total

1.  Pyrimidine ribonucleotides with enhanced selectivity as P2Y(6) receptor agonists: novel 4-alkyloxyimino, (S)-methanocarba, and 5'-triphosphate gamma-ester modifications.

Authors:  Hiroshi Maruoka; Matthew O Barrett; Hyojin Ko; Dilip K Tosh; Artem Melman; Lauren E Burianek; Ramachandran Balasubramanian; Barkin Berk; Stefano Costanzi; T Kendall Harden; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2010-06-10       Impact factor: 7.446

Review 2.  Signalling and pharmacological properties of the P2Y receptor.

Authors:  T K Harden; J I Sesma; I P Fricks; E R Lazarowski
Journal:  Acta Physiol (Oxf)       Date:  2010-03-24       Impact factor: 6.311

3.  Design, synthesis, pharmacological characterization of a fluorescent agonist of the P2Y₁₄ receptor.

Authors:  Evgeny Kiselev; Ramachandran Balasubramanian; Elisa Uliassi; Kyle A Brown; Kevin Trujillo; Vsevolod Katritch; Eva Hammes; Raymond C Stevens; T Kendall Harden; Kenneth A Jacobson
Journal:  Bioorg Med Chem Lett       Date:  2015-08-10       Impact factor: 2.823

Review 4.  Nucleotides Acting at P2Y Receptors: Connecting Structure and Function.

Authors:  Kenneth A Jacobson; Silvia Paoletta; Vsevolod Katritch; Beili Wu; Zhan-Guo Gao; Qiang Zhao; Raymond C Stevens; Evgeny Kiselev
Journal:  Mol Pharmacol       Date:  2015-04-02       Impact factor: 4.436

Review 5.  UDP-Sugars as Extracellular Signaling Molecules: Cellular and Physiologic Consequences of P2Y14 Receptor Activation.

Authors:  Eduardo R Lazarowski; T Kendall Harden
Journal:  Mol Pharmacol       Date:  2015-03-31       Impact factor: 4.436

6.  Pyrimidine Nucleotides Containing a (S)-Methanocarba Ring as P2Y6 Receptor Agonists.

Authors:  Kiran S Toti; Shanu Jain; Antonella Ciancetta; Ramachandran Balasubramanian; Saibal Chakraborty; Ryan Surujdin; Zhen-Dan Shi; Kenneth A Jacobson
Journal:  Medchemcomm       Date:  2017-09-06       Impact factor: 3.597

7.  Molecular modeling of the human P2Y14 receptor: A template for structure-based design of selective agonist ligands.

Authors:  Kevin Trujillo; Silvia Paoletta; Evgeny Kiselev; Kenneth A Jacobson
Journal:  Bioorg Med Chem       Date:  2015-03-21       Impact factor: 3.641

8.  Human P2Y(14) receptor agonists: truncation of the hexose moiety of uridine-5'-diphosphoglucose and its replacement with alkyl and aryl groups.

Authors:  Arijit Das; Hyojin Ko; Lauren E Burianek; Matthew O Barrett; T Kendall Harden; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2010-01-14       Impact factor: 7.446

9.  Enhanced potency of nucleotide-dendrimer conjugates as agonists of the P2Y14 receptor: multivalent effect in G protein-coupled receptor recognition.

Authors:  Arijit Das; Yixing Zhou; Andrei A Ivanov; Rhonda L Carter; T Kendall Harden; Kenneth A Jacobson
Journal:  Bioconjug Chem       Date:  2009-07-02       Impact factor: 4.774

10.  UDP-glucose acting at P2Y14 receptors is a mediator of mast cell degranulation.

Authors:  Zhan-Guo Gao; Yi Ding; Kenneth A Jacobson
Journal:  Biochem Pharmacol       Date:  2009-11-05       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.